Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine for Presbyvestibulopathy
NCT05932979Phase 2Withdrawn
- Sponsor
- Centro Universitario de Tonalá
- Start
- May 2023
- Primary completion
- Nov 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in presbyvestibulopathy (PVP), sponsored by Centro Universitario de Tonalá. Planned start May 2023; status: withdrawn.
02
Drugs
arginine
03
Conditions
presbyvestibulopathy (PVP)
Beyond the preview
Go deeper on NCT05932979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05932979.